An interventional study of Interactive AI Video Avatar and Personalized GPT Interface in Artifical Intelligence, Generative Artificial Intelligence and Education, Nursing Students, sponsored by Manisa Celal Bayar University. Not yet recruiting. Per ClinicalTrials.gov, last updated 2026-10-27.
Sponsored by Manisa Celal Bayar University · Not applicable, Interventional, and Other
The goal of this study is to evaluate and compare the effectiveness of two generative artificial intelligence technologies (an interactive AI video avatar vs. a personalized GPT) in enhancing professional English learning, overall tool satisfaction, and attitudes toward generative AI. The study will be conducted in undergraduate third-year nursing students enrolled in a professional English course at a university health sciences faculty in Türkiye.
The main questions it aims to answer are:
Participants will:
Manisa Celal Bayar University is the lead sponsor of 34 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Other: Interactive AI Video Avatar
Other: Personalized GPT Interface
Participants will voluntarily use an interactive AI video avatar as a supplementary tool in their Professional English III course over a 15-week semester. The avatar provides visual and auditory simulations of clinical nursing communication.
Participants will voluntarily use a personalized Large Language Model (GPT) interface configured to act as an adaptive, text- and voice-based learning partner integrated as a supplementary tool in the "Professional English III" nursing curriculum.
Change in Professional English Knowledge Test Score
It is assessed by the Professional English Knowledge Test. It evaluates the professional English language proficiency of nursing students, covers clinical nursing terminology, nurse-patient therapeutic communication, patient education, and taking patient history. The test comprises 20 multiple-choice questions tailored to the course objectives. Higher total scores indicate greater professional English knowledge and language competency.
Time frame: From enrollment to the end of application at 15 weeks
Change in Attitudes Toward Generative Artificial Intelligence in English Learning
It is assessed by the Generative Artificial Intelligence Attitude Scale for EFL Learners (GenAIAS). It assesses students' attitudes toward generative artificial intelligence in English learning. The scale comprises 33 items rated on a 5-point Likert scale (1=Strongly Disagree to 5=Strongly Agree), covering four sub-dimensions: Learning, Enjoyment, Usefulness, and Interest. The total score ranges from a minimum of 33 to a maximum of 165 points. Higher scores indicate more positive attitudes toward generative AI in English language learning.
Time frame: From enrollment to the end of application at 15 weeks
Overall Educational AI Tool Satisfaction
It is assessed by the Visual Analogue Scale (VAS). It evaluates overall participant satisfaction with their assigned educational AI tool. Participants mark their response on a continuous line anchored from "very bad" (0 mm) to "very good" (100 mm). Higher scores indicate higher satisfaction with the assigned educational AI tool.
Time frame: At the end of application at 15 weeks
No study locations are listed for this record.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Manisa Celal Bayar University